# Sources — Ella Fitzgerald

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

Accessed November 4, 2026. The canonical source metadata and claim links are in `case.json`.

## Historical evidence

1. “‘The Greatest’: Ella Fitzgerald dies; singer expanded boundaries of jazz with warm sound, acrobatic style.” *The Spokesman-Review* (wire reports), June 16, 1996. Supports that her birth certificate and school records show her born on April 25, 1917, in Newport News, Virginia, although most biographies gave 1918; her 1934 win at the Apollo Theater amateur contest and Chick Webb’s attention; that she “had been suffering from diabetes and its circulatory system complications for many years”; that in 1993 both legs were amputated below the knees; and that she died at home in Beverly Hills at 79. https://www.spokesman.com/stories/1996/jun/16/the-greatest-ella-fitzgerald-dies-singer-expanded/
2. American Masters (PBS). “Ella Fitzgerald: career timeline.” Supports her birth to Temperance and William Fitzgerald; her mother’s sudden death from a heart attack in 1932 and her placement in the Colored Orphan Asylum in Riverdale at 15; her first recording with Chick Webb in 1935; “A-Tisket A-Tasket” in 1938; her 1958 Grammy; the Kennedy Center award in 1979; her admission to intensive care for heart trouble in 1986; the National Medal of Freedom in 1992; and her death on June 15, 1996, which the timeline attributes to complications from diabetes. https://www.pbs.org/wnet/americanmasters/ella-fitzgerald-career-timeline/591/
3. Newsweek. “Scat lady” (obituary, 1996). Supports that in the 1970s, after cataract surgery, she returned to touring more than 40 weeks a year; her quintuple-bypass heart surgery in 1986 and her return to the stage the following year; her 1989 words about her convalescence (“Staying home and being bored … I miss the road. I miss going overseas.”); that her health had declined since 1993, when both legs were amputated below the knees because of complications from diabetes; and that the exact cause of death was not released. https://www.newsweek.com/scat-lady-178732
4. VOA Learning English. “Ella Fitzgerald, 1917-1996: America’s First Lady of Song.” Supports that her health problems began in the 1970s, that she had diabetes, which caused problems with her eyes, that she had a heart operation in 1986, that in 1993 the effects of diabetes led to operations to remove both her legs, and the title “America’s first lady of song.” https://learningenglish.voanews.com/a/ella-fitzgerald-1917-1996-americas-first-lady-of-song-97708054/114092.html
5. The Ella Fitzgerald Charitable Foundation (official site). Supports that the foundation was created and funded by her in 1993 and that one of its areas of interest is medical care and research with an emphasis on diabetes, vision problems, and heart disease. https://www.ellafitzgerald.com/foundation
6. HISTMED Master Roster v3. Internal project source; its summary (type 2 diabetes with peripheral artery disease and amputation; diabetic eye disease) was checked against the sources above. The roster’s “type 2” is not stated in any fetched source.

## Clinical guidance

1. American Diabetes Association. Standards of Care in Diabetes—2026. *Diabetes Care* 2026;49(Suppl 1): section 6 (glycemic goals and hypoglycemia, PMID 41358894), section 7 (diabetes technology, PMID 41358889), section 9 (pharmacologic treatment, PMID 41358900), section 10 (cardiovascular disease and risk management, PMID 41358899), section 12 (retinopathy, neuropathy, and foot care, PMID 41358886), and section 13 (older adults, PMID 41358888). The guideline URL in `case.json` points to section 12. https://pubmed.ncbi.nlm.nih.gov/41358886/
2. Schaper NC, et al. Practical guidelines on the prevention and management of diabetes-related foot disease (IWGDF 2023 update). *Diabetes Metab Res Rev* 2024 (PMID 37243927). Risk stratification (category 2: peripheral artery disease with foot deformity, screened every three to six months), protective footwear, callus care, and education. https://pubmed.ncbi.nlm.nih.gov/37243927/
3. Fitridge R, et al. The intersocietal IWGDF, ESVS, SVS guidelines on peripheral artery disease in people with diabetes and a foot ulcer (2023; PMID 37726988). Toe pressures and toe-brachial index when ankle pressures may be falsely raised, and prompt vascular assessment. https://pubmed.ncbi.nlm.nih.gov/37726988/
4. Gornik HL, et al. 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease. *Circulation* 2024 (PMID 38743805). Ankle-brachial index and toe-brachial index, supervised exercise therapy, high-intensity statin therapy, antiplatelet therapy and low-dose rivaroxaban with aspirin, glucose-lowering drugs with cardiovascular benefit, foot care, revascularization for lifestyle-limiting claudication after guideline-directed therapy, and attention to disparities in amputation. https://pubmed.ncbi.nlm.nih.gov/38743805/
5. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (PMID 37471501). https://pubmed.ncbi.nlm.nih.gov/37471501/
6. Bonaca MP, et al. Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE). *Lancet* 2025 (PMID 40169145). A trial, recorded with the guidelines because the case relies on it: semaglutide increased walking distance. https://pubmed.ncbi.nlm.nih.gov/40169145/
7. CMID: Clinical Monitoring Intelligence Database (Aether Forge, 2026), diabetes mellitus (type 2) and ischemic heart disease monographs. A1c every three months when not at goal, lipid panel 4 to 12 weeks after a statin change and LDL below 55 mg/dL with ASCVD, yearly urine albumin-creatinine ratio and eGFR, the comprehensive foot examination (every visit with high-risk findings), retinal examination yearly with retinopathy, hypoglycemia review at every visit on insulin, vitamin B12 on metformin, and the cognitive and functional screens at 65 and older. https://patrickrutledge.github.io/topthirty/
8. CMS Medicare Wellness Visits; Medicare Preventive Services reference (Aether Forge, 2026); U.S. Preventive Services Task Force recommendations on depression (2023), falls (2024), breast cancer (2024), osteoporosis (2025), colorectal cancer (2021), hepatitis C (2020), and alcohol (2018); CDC Adult Immunization Schedule by Age (2026).

## Editorial resolutions

- **Recent-death rule.** She died in 1996, so the rule applies. Every health claim comes from public reports: a 1996 wire obituary, the PBS American Masters timeline, a Newsweek obituary, VOA Learning English, and her foundation’s own page. No medical record, physician statement, family account, biography, or speculation is used. No sick visit is added. No claim concerns mental health or substance use. Her death is recorded in one sentence (CLM-0014), which notes that the cause was not released.
- **What is and is not on the public record.** The record documents diabetes with eye problems from the 1970s, cataract surgery in the 1970s, intensive care and quintuple-bypass heart surgery in 1986, “circulatory system complications” of diabetes, and the 1993 amputation of both legs below the knee. The type of diabetes, its treatment, every laboratory and imaging value, the grade of retinopathy, the location of the arterial disease, the medicines, and the outcomes in the modern episode are synthetic. No diagnosis beyond these reported conditions is added: kidney function and urine albumin are normal, no neuropathy is diagnosed (protective sensation is intact), and no heart failure, hypertension, or hyperlipidemia diagnosis is coded; the statin, ezetimibe, aspirin, rivaroxaban, and metoprolol are indicated by the coronary and peripheral artery disease. Low glucose readings are part of the synthetic treatment history and are not coded as a separate diagnosis.
- **Amputations.** The 1993 amputations (CLM-0011) are history only. They fall six years after the true-frame episode, are linked only to the 1993 timeline event, and do not appear in the intake documents. The modern episode neither stages nor predicts them: the arterial disease improves with supervised exercise and medical therapy, no wound occurs, and revascularization is planned if claudication again limits her life or any threat to the limb appears.
- **Birth date.** April 25, 1917 is from her birth certificate and school records as reported in the 1996 obituary and the PBS timeline; 1918, given in most earlier biographies, is recorded as a conflicting alternative.
- **Index age and dates.** The index visit on May 11, 2026 maps to May 11, 1987, when she was 70: the year after her 1986 heart surgery, when she was back on stage, and six years before the amputations. The synthetic date of birth is April 25, 1956 (shift 39 years). The visits on May 26, June 15, August 10, and October 26, 2026 map to the same days of 1987. The coronary bypass surgery “last year” in the modern episode stands for the 1986 operation; the medicine start date of June 2, 2025 stands for the treatment begun after it.
- **Real people.** Her parents, Chick Webb, and her mother’s death appear only in the claims and family history; her mother’s death from a heart attack is the only family history, as the PBS timeline gives it. No modern decision, statement, or health fact is attributed to any real person. Her road manager, dresser, and musicians in the modern episode are unnamed and synthetic. The aliases “Ella Jane Fitzgerald” and “First Lady of Song” appear in no other record, and no other figure with a record is named.
- **Equity and access.** The modern episode treats access as part of the clinical plan (scheduling around tours, video visits, large print for her vision, drug-cost checks, coordination with clinics in tour cities) and the consultant notes the higher rates of amputation, often without a vascular assessment first, in people with diabetes, in Black Americans, and in people with less access to care, as the ACC/AHA guideline describes. No fetched source describes her own experiences of access to care, and none is invented.
- **Laterality of the ankle-brachial index.** LOINC 77194-9 (ankle-brachial index) has no side; the right and left values carry the same code and are told apart by their labels. The toe-brachial indices use the side-specific LOINC codes.
- **Annual wellness visit.** A subsequent annual wellness visit at 70 (HCPCS G0439, CPT 99497, G0009, and CPT 90677 in plain text) with the Mini-Cog, PHQ-2, AUDIT-C, Timed Up and Go, PCV20, mammography and bone density orders, hepatitis C screening (negative at three months), and advance care planning with an unnamed agent. The influenza and first recombinant zoster vaccines were given at the October visit.
- **Focused visits.** The three chronic-care follow-ups (two weeks with the consultation, three months, and five and a half months) are documented as focused visits on the ADA Standards of Care 2026, IWGDF 2023, the 2024 ACC/AHA PAD guideline, the 2023 chronic coronary disease guideline, and the CMID diabetes monograph. Deviation recorded instead of an invented result: the lipid panel due 4 to 12 weeks after atorvastatin was raised was drawn at 13 weeks because she was on tour; no harm, and tests after any change are now booked before tours. The six-month vascular review with ankle-brachial index and duplex falls after the last visit and is recorded as due. The retina-clinic injections and podiatry visits are recorded as procedures on their own dates, outside the clinic visits.
- **Consultation.** The referral and the consultation by Marcus Okafor-Lane, MD (a fictional vascular surgeon), on the day of the two-week visit, are **S**. The consultant answers the five referral questions in line with what the record shows afterwards: femoropopliteal disease on duplex; supervised exercise with a home plan on tour (completed, walking distance tripled); low-dose rivaroxaban with aspirin (started that day, no bleeding); no revascularization now, with stated triggers (none occurred, and the decision was confirmed at five and a half months); ezetimibe if LDL stayed at 55 mg/dL or above (added at three months) and semaglutide worth considering (started at three months); and review at six months.
- **Synthetic content.** All visits, laboratory values, indices, acuity, CGM data, vital signs, scores, the medicines and doses, the procedures, her height (165 cm) and weight, and the modern social history are synthetic. Qualitative results (duplex, hepatitis C, mammogram) appear only in the note text.
- **Not used.** Biographies, documentaries, interviews about her health other than the 1989 quotation, accounts by her family, staff, or physicians, and reports of her last concerts were not used. One secondary source’s report of heart failure and a valve replacement in 1986 was not corroborated and is not used.
